498 related articles for article (PubMed ID: 18286380)
21. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
Taylor R; Morrell S; Mamoon H; Wain G; Ross J
Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
[TBL] [Abstract][Full Text] [Related]
22. Invasive cervical cancer: a failure of screening.
Spayne J; Ackerman I; Milosevic M; Seidenfeld A; Covens A; Paszat L
Eur J Public Health; 2008 Apr; 18(2):162-5. PubMed ID: 17483491
[TBL] [Abstract][Full Text] [Related]
23. Association between sexual behavior and cervical cancer screening.
Smith AM; Heywood W; Ryall R; Shelley JM; Pitts MK; Richters J; Simpson JM; Patrick K
J Womens Health (Larchmt); 2011 Jul; 20(7):1091-6. PubMed ID: 21682554
[TBL] [Abstract][Full Text] [Related]
24. Social and cultural barriers to Papanicolaou test screening in an urban population.
Behbakht K; Lynch A; Teal S; Degeest K; Massad S
Obstet Gynecol; 2004 Dec; 104(6):1355-61. PubMed ID: 15572502
[TBL] [Abstract][Full Text] [Related]
25. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
26. Screening differences and risk of cervical cancer in inflammatory bowel disease.
Hutfless S; Fireman B; Kane S; Herrinton LJ
Aliment Pharmacol Ther; 2008 Sep; 28(5):598-605. PubMed ID: 18549465
[TBL] [Abstract][Full Text] [Related]
27. Is a history of trauma associated with a reduced likelihood of cervical cancer screening?
Farley M; Golding JM; Minkoff JR
J Fam Pract; 2002 Oct; 51(10):827-31. PubMed ID: 12401150
[TBL] [Abstract][Full Text] [Related]
28. [Organized cervical cancer screening for underpriviledged women].
Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
[TBL] [Abstract][Full Text] [Related]
29. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
30. Pressing the key pad: trial of a novel approach to health promotion advice.
Corkrey R; Parkinson L; Bates L
Prev Med; 2005 Aug; 41(2):657-66. PubMed ID: 15917066
[TBL] [Abstract][Full Text] [Related]
31. [Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer].
Makino H; Sato S; Yajima A; Fukao A
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1226-32. PubMed ID: 1919184
[TBL] [Abstract][Full Text] [Related]
32. Papanicolaou smear screening interval and risk of cervical cancer.
Shy K; Chu J; Mandelson M; Greer B; Figge D
Obstet Gynecol; 1989 Dec; 74(6):838-43. PubMed ID: 2586947
[TBL] [Abstract][Full Text] [Related]
33. Invasive cervical cancer among Hispanic and non-Hispanic women--United States, 1992-1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(47):1067-70. PubMed ID: 12500907
[TBL] [Abstract][Full Text] [Related]
34. [Knowledge and use of Pap-smear among HIV-positive women].
Pavia C; Navarra A; Pisani G; Piselli P; Koehler B; Angeletti C; Ippolito G; Serraino D
Minerva Ginecol; 2006 Jun; 58(3):233-8. PubMed ID: 16783295
[TBL] [Abstract][Full Text] [Related]
35. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
Thoresen SO; Skare GB; Sandvin O
Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
[TBL] [Abstract][Full Text] [Related]
36. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
[TBL] [Abstract][Full Text] [Related]
37. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study.
Singh H; Demers AA; Nugent Z; Mahmud SM; Kliewer EV; Bernstein CN
Gastroenterology; 2009 Feb; 136(2):451-8. PubMed ID: 18996382
[TBL] [Abstract][Full Text] [Related]
38. Screening history of women in Malmö with invasive cervical cancer.
Lindqvist PG; Hellsten C; Rippe A
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of a call/recall system in improving compliance with cervical cancer screening: a randomized controlled trial.
Buehler SK; Parsons WL
CMAJ; 1997 Sep; 157(5):521-6. PubMed ID: 9294390
[TBL] [Abstract][Full Text] [Related]
40. Women at risk: papanicolaou smear screening in Florida.
Vincent AL; Greene JN; Hoercherl S; McTague D
J Fla Med Assoc; 1997; 84(5):302-7. PubMed ID: 9260433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
